Position in MRK
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$61,423
+$4,165 QoQ
Shares Held
478
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#3,637
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roble, Belko & Company, Inc holds $3,192,754 across 12 Drug Manufacturers - General names. MRK ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,506 | $1,385,529 | |
| 2 | JNJ |
Johnson & Johnson
|
3,549 | $901,339 | |
| 3 | LLY |
ELI LILLY & Co
|
416 | $498,962 | |
| 4 | PFE |
Pfizer Inc
|
8,245 | $198,539 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
478 | $61,423 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
919 | $52,952 | |
| 7 | GSK |
GSK plc
|
685 | $35,907 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
218 | $27,542 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,423 | 478 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $57,258 | 476 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $49,998 | 475 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $35,502 | 423 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $39,975 | 505 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $51,791 | 577 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $32,430 | 326 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $37,020 | 326 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $40,358 | 326 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $43,015 | 326 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $26,273 | 241 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $19,766 | 192 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $22,154 | 192 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $274,273 | 2,578 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $550,755 | 4,964 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $427,499 | 4,964 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $452,567 | 4,964 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $407,296 | 4,964 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $386,495 | 5,043 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $372,846 | 4,964 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $386,050 | 4,964 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $382,674 | 4,964 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $406,055 | 4,964 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $411,763 | 4,964 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $415,030 | 5,367 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $381,930 | 4,964 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||